Literature DB >> 8913125

The venous closing pressure in central retinal vein obstruction.

A P Luckie1, J J Wroblewski, A C Bird, A M Hamilton, M D Sanders, W Green, N G Slater.   

Abstract

OBJECTIVE: To assess the rate of change in the central retinal venous closing pressure in central retinal vein obstruction over time, and its relationship to visual acuity improvement and the development of rubeosis iridis.
METHODS: Fifty patients presenting with central retinal vein obstruction of less than three months' duration, between the ages of 40 and 80 years, were reviewed prospectively. The central retinal venous closing pressure was measured by digital ocular compression. Patients were discharged from the study after the six-month visit.
RESULTS: All patients had elevated venous closing pressure at presentation, whereas at six months only 24 patients had persistent elevation. Of 16 patients with lowering of the venous closing pressure within four months of onset of central retinal vein obstruction, 11 (69%) had two or more lines of visual acuity improvement. Only two of 10 patients (20%) developing lowering of the venous closing pressure thereafter had visual improvement. No patient developed rubeosis iridis after the venous closing pressure lowered.
CONCLUSION: The central retinal venous closing pressure is raised in central retinal vein obstruction to about central retinal arterial diastolic pressure, and is its pathognomonic sign. This sign is easily elicited via digital pressure on the eyelid, and has prognostic significance for visual acuity improvement and the development of rubeosis iridis.

Entities:  

Mesh:

Year:  1996        PMID: 8913125     DOI: 10.1111/j.1442-9071.1996.tb01585.x

Source DB:  PubMed          Journal:  Aust N Z J Ophthalmol        ISSN: 0814-9763


  2 in total

1.  Linear interactions between intraocular, intracranial pressure, and retinal vascular pulse amplitude in the fourier domain.

Authors:  Anmar Abdul-Rahman; William Morgan; Ying Jo Khoo; Christopher Lind; Allan Kermode; William Carroll; Dao-Yi Yu
Journal:  PLoS One       Date:  2022-06-28       Impact factor: 3.752

2.  A treat and extend protocol with Aflibercept for cystoid macular oedema secondary to central retinal vein occlusion - an 18-month prospective cohort study.

Authors:  Roderick O'Day; Noha Ali; Lyndell L Lim; Sukhpal Sandhu; Thuy Chau; Sanjeewa Wickremasinghe
Journal:  BMC Ophthalmol       Date:  2020-02-24       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.